Utah Medical Products, Inc. Announces Quarterly Dividend
Utah Medical Products (NASDAQ:UTMD) has announced a quarterly cash dividend of $0.305 per share of common stock. The dividend will be payable on October 2, 2025, to stockholders of record at the close of business on September 17, 2025.
This represents a 1.7% increase compared to the dividend declared in the same quarter of the previous year. The company specializes in healthcare products for women and their babies, manufacturing specialty medical devices used by clinicians globally.
Utah Medical Products (NASDAQ:UTMD) ha annunciato un dividendo trimestrale in contanti di 0,305 dollari per azione di azioni ordinarie. Il dividendo sarà pagabile il 2 ottobre 2025 agli azionisti registrati alla chiusura delle contrattazioni del 17 settembre 2025.
Si tratta di un aumento dell'1,7% rispetto al dividendo dichiarato nello stesso trimestre dell'anno precedente. L'azienda è specializzata in prodotti sanitari per donne e neonati, producendo dispositivi medici specializzati utilizzati da operatori sanitari in tutto il mondo.
Utah Medical Products (NASDAQ:UTMD) ha anunciado un dividendo trimestral en efectivo de 0,305 dólares por acción de acciones comunes. El dividendo se pagará el 2 de octubre de 2025 a los accionistas registrados al cierre del mercado el 17 de septiembre de 2025.
Esto representa un aumento del 1,7% en comparación con el dividendo declarado en el mismo trimestre del año anterior. La empresa se especializa en productos de salud para mujeres y sus bebés, fabricando dispositivos médicos especializados usados por profesionales clínicos a nivel mundial.
Utah Medical Products (NASDAQ:UTMD)는 보통주 1주당 0.305달러의 분기 현금 배당을 발표했습니다. 배당금은 2025년 10월 2일에 지급되며, 2025년 9월 17일 거래 종료 시점에 주주명부에 등재된 주주에게 지급됩니다.
이는 전년도 같은 분기에 선언된 배당금 대비 1.7% 증가한 수치입니다. 이 회사는 여성과 아기를 위한 의료 제품을 전문으로 하며, 전 세계 임상가들이 사용하는 특수 의료기기를 제조합니다.
Utah Medical Products (NASDAQ:UTMD) a annoncé un dividende trimestriel en espèces de 0,305 $ par action d’actions ordinaires. Le dividende sera versé le 2 octobre 2025 aux actionnaires inscrits au registre à la clôture des échanges le 17 septembre 2025.
Cela représente une augmentation de 1,7 % par rapport au dividende déclaré au même trimestre de l’année précédente. L’entreprise est spécialisée dans les produits de santé pour les femmes et leurs bébés, fabriquant des dispositifs médicaux spécialisés utilisés par des cliniciens dans le monde entier.
Utah Medical Products (NASDAQ:UTMD) hat eine vierteljährliche Bardividende von 0,305 USD pro Aktie der Stammaktien angekündigt. Die Dividende wird am 2. Oktober 2025 an die zum Geschäftsschluss am 17. September 2025 eingetragenen Aktionäre ausgezahlt.
Dies entspricht einer Steigerung von 1,7 % gegenüber der im gleichen Quartal des Vorjahres erklärten Dividende. Das Unternehmen ist auf Gesundheitsprodukte für Frauen und deren Babys spezialisiert und stellt weltweit von Klinikern eingesetzte Spezial-Medizinprodukte her.
- Dividend increased by 1.7% year-over-year
- Consistent dividend payment demonstrates financial stability
- Global market presence in over 100 countries
- None.
SALT LAKE CITY, UT / ACCESS Newswire / July 29, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty and one-half cents ($.305) per share of common stock payable on October 2, 2025 to stockholders of record at the close of business on September 17, 2025. This is a
Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hundred countries around the world as the standard for obtaining optimal long-term outcomes for their patients. For more information about Utah Medical Products, Inc., visit UTMD's website at www.utahmed.com.
Contact:
Brian Koopman
(801) 566-1200
SOURCE: Utah Medical Products, Inc.
View the original press release on ACCESS Newswire